BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23091368)

  • 1. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
    J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
    Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis.
    Fan NJ; Gao CF; Zhao G; Wang XL; Liu QY
    Diagn Pathol; 2012 Apr; 7():45. PubMed ID: 22521044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
    Li K; He WH; Fan NJ; Gao CF; Zhao G; Sun GB; Zheng GB
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():147-52. PubMed ID: 25910294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.
    Fan NJ; Kang R; Ge XY; Li M; Liu Y; Chen HM; Gao CF
    Diagn Pathol; 2014 Mar; 9():53. PubMed ID: 24618180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
    Fan NJ; Gao CF; Zhao G; Wang XL; Qiao L
    Biotechnol Appl Biochem; 2012; 59(4):276-82. PubMed ID: 23586861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
    Ying X; Han SX; Wang JL; Zhou X; Jin GH; Jin L; Wang H; Wu L; Zhang J; Zhu Q
    Diagn Pathol; 2013 Aug; 8():130. PubMed ID: 23915185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
    Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
    J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Fiedler GM; Baumann S; Leichtle A; Oltmann A; Kase J; Thiery J; Ceglarek U
    Clin Chem; 2007 Mar; 53(3):421-8. PubMed ID: 17272489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
    World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
    Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
    Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
    Liu C; Pan C; Shen J; Wang H; Yong L
    Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Guo R; Pan C; Shen J; Liu C
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):513-9. PubMed ID: 20490864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
    Wan QL; Hou XS; Zhao G
    Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
    Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
    Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.